Efficacy of Two Chlorhexidine Solutions to Control the Initial Subgingival Biofilm Formation
NCT ID: NCT02656251
Last Updated: 2016-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
35 participants
INTERVENTIONAL
2015-07-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Triclosan Formulation to Control the Initial Subgingival Biofilm Formation
NCT02192060
Staining and Calculus Formation After 0.12% Chlorhexidine Rinses
NCT00818376
Antibacterial Effect and Substantivity of a New Chlorhexidine and Cymenol Gel on Oral Biofilm and Saliva
NCT06437262
Evaluation of the Effect of a Toothpaste Containing 0.3% Chlorhexidine in Subjects With Established Dental Plaque and Gingivitis
NCT06732466
Evaluation of Techniques for Scaling and Root Planing and One Stage Full Mouth Disinfection
NCT02126267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0.12% Clorhexidine with alcohol
0.12% Clorhexidine with alcohol, 15ml every 12 hour for 4 days
0.12% Clorhexidine with alcohol
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
placebo
Use of placebo every 12 hours for 04 days
0.12% Clorhexidine without alcohol
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
0.12% Clorhexidine without alcohol
0.12% Clorhexidine without alcohol, 15ml every 12 hour for 4 days
0.12% Clorhexidine with alcohol
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
placebo
Use of placebo every 12 hours for 04 days
0.12% Clorhexidine without alcohol
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
control
placebo 15ml every 12 hour for 4 days
0.12% Clorhexidine with alcohol
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
placebo
Use of placebo every 12 hours for 04 days
0.12% Clorhexidine without alcohol
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
0.12% Clorhexidine with alcohol
Use of 0.12% Clorhexidine with alcohol every 12 hours for 04 days
placebo
Use of placebo every 12 hours for 04 days
0.12% Clorhexidine without alcohol
Use of 0.12% Clorhexidine without alcohol, every 12 hours for 04 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* non-smokers;
* have good general health;
* present at least 20 natural teeth in the mouth, including the incisors, canines and premolars without restorations, crowns, gingival recession, anatomic defects, gingivitis e/or periodontitis.
Exclusion Criteria
* positive history of allergies at using Triclosan;
* pregnant or lactating patients;
* patients in use of fixed orthodontic appliance.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Rio Grande do Sul
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patricia Weidlich
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia Weidlich, PhD
Role: STUDY_DIRECTOR
Federal University of Rio Grande do Sul
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
URio Grande
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.